Durvalumab plus cisplatin and gemcitabine in advanced biliary tract cancer: can we do it better?

ABSTRACT:

SUBMITTER: Rimini M 

PROVIDER: S-EPMC12521034 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature